Novartis and DNDi to jointly develop a new oral drug to treat visceral leishmaniasis - EurekAlert

Novartis and DNDi to jointly develop a new oral drug to treat visceral leishmaniasis  EurekAlert

Comments

Popular posts from this blog

Roseola rash: symptoms, pictures, and treatment - Medical News Today

CDC says skin-disfiguring parasite may be endemic in Texas, present in other states - NBC News